February 2014

U.S. Attorney for the District of Massachusetts, Carmen Ortiz, emphasized the importance of compliance programs early on during…

Recently the U.S. Department of Health & Human Services Office of Inspector General issued a report on its "key focus areas"…

The U.S. Department of Justice (DOJ) recently announced a $40.1 million final settlement agreement with CareFusion Corp. to…

At the recent CBI Pharmaceutical Compliance Congress, U.S. Attorney for the District of New Jersey, Paul Fishman, discussed…

In his remarks at the CBI Pharmaceutical Compliance Congress, Assistant Attorney General, Civil Division, Stuart Delery emphasized…

CMS announced important information regarding registration and data submission for the 2013 - Open Payments Program Year. The…

The Centers for Medicare & Medicaid Services (CMS) and the Office for the National Coordinator (ONC) for Health IT announced…

As part of Washington D.C.'s National Disclosure Summit, PwC presented on "Compliance Data Metrics and Analytics." The…

The CBI Compliance Congress offered insight into how industry has approached Sunshine Act reporting. The presentation "Strategies…

As part of CBI's Pharmaceutical Compliance Congress, Tom Abrams, director of the Food and Drug Administration's (FDA) Office of…